https://www.selleckchem.com/pr....oducts/lificiguat-yc
useful. These results support the use of a high index of suspicion for performing CTPA to exclude or confirm APE as the most appropriate diagnostic approach in this clinical setting. This article is protected by copyright. All rights reserved. Pharmacoepidemiologic multi-database studies (MDBS) provide opportunities to better evaluate the safety and effectiveness of medicines. However, the issue of missing data is often exacerbated in MDBS, potentially resulting in bias and precision loss. We sought to measure how missing data a
Curtir
Comentario
Compartilhar
